Data

Hepatitis B incidence per 100,000 population

data.gov.au
Sustainable Development Goals (Owned by)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=http://data.gov.au/data/dataset/f93905c2-1041-4f33-b055-7752549a3b67&rft.title=Hepatitis B incidence per 100,000 population&rft.identifier=hepatitis-b-incidence-per-100-000-population&rft.publisher=data.gov.au&rft.description=Hepatitis B incidence per 100,000 population - Notification Rate of Hepatitis B (unspecified), 2015 to 2020.\r\n\r\nRates are not available per 1,000 population, however they are available per 100,000 population.\r\n\r\nHepatitis B cases are notified as either: newly acquired, where evidence was available that the infection was acquired within 24 months prior to diagnosis; or unspecified, where the infection was acquired more than 24 months prior diagnosis or the period of infection is unspecified. \r\n\r\nDetermination of a case as newly acquired is reliant on public health follow-up and the availability of previous serology test results, with the method and intensity of follow-up varying by jurisdiction and over time. This makes interpretation of incidence using only notification data difficult. For the purposes of this indicator notification rates for both unspecified and newly acquired hepatitis B are presented in the table below and represent prevalence as a surrogate for incidence.\r\n\r\nIt is important to recognise that for hepatitis B infections, notifications to the National Notifiable Disease Surveillance System (NNDSS) represent only a proportion of the total cases and may be influenced by changes to testing patterns.\r\n\r\nFurther information can be found here > http://www9.health.gov.au/cda/source/cda-index.cfm \r\nNotification Rate of Hepatitis B per 100,000 population, 2015 to 2020\r\n\r\nRates are not available per 1,000 population, however they are available per 100,000 population.\r\n\r\nHepatitis B cases are notified as either: newly acquired, where evidence was available that the infection was acquired within 24 months prior to diagnosis; or unspecified, where the infection was acquired more than 24 months prior diagnosis or the period of infection is unspecified. \r\n\r\nDetermination of a case as newly acquired is reliant on public health follow-up and the availability of previous serology test results, with the method and intensity of follow-up varying by jurisdiction and over time. This makes interpretation of incidence using only notification data difficult. For the purposes of this indicator notification rates for both unspecified and newly acquired hepatitis B are presented in the table below and represent prevalence as a surrogate for incidence.\r\n\r\nIt is important to recognise that for hepatitis B infections, notifications to the National Notifiable Disease Surveillance System (NNDSS) represent only a proportion of the total cases and may be influenced by changes to testing patterns.\r\n\r\nFurther information can be found here > http://www9.health.gov.au/cda/source/cda-index.cfm \r\n\r\n&rft.creator=Sustainable Development Goals&rft.date=2023&rft.coverage=Australia&rft_rights=Creative Commons Attribution 4.0 International http://creativecommons.org/licenses/by/4.0&rft_subject=Disease&rft_subject=Hepatitis-B&rft_subject=Incidence&rft_subject=Sustainable Development Goals&rft.type=dataset&rft.language=English Access the data

Licence & Rights:

Open Licence view details
CC-BY

Creative Commons Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0

Brief description

Notification Rate of Hepatitis B per 100,000 population, 2015 to 2020

Rates are not available per 1,000 population, however they are available per 100,000 population.

Hepatitis B cases are notified as either: newly acquired, where evidence was available that the infection was acquired within 24 months prior to diagnosis; or unspecified, where the infection was acquired more than 24 months prior diagnosis or the period of infection is unspecified.

Determination of a case as newly acquired is reliant on public health follow-up and the availability of previous serology test results, with the method and intensity of follow-up varying by jurisdiction and over time. This makes interpretation of incidence using only notification data difficult. For the purposes of this indicator notification rates for both unspecified and newly acquired hepatitis B are presented in the table below and represent prevalence as a surrogate for incidence.

It is important to recognise that for hepatitis B infections, notifications to the National Notifiable Disease Surveillance System (NNDSS) represent only a proportion of the total cases and may be influenced by changes to testing patterns.

Further information can be found here > http://www9.health.gov.au/cda/source/cda-index.cfm

Full description

Hepatitis B incidence per 100,000 population - Notification Rate of Hepatitis B (unspecified), 2015 to 2020.\r\n\r\nRates are not available per 1,000 population, however they are available per 100,000 population.\r\n\r\nHepatitis B cases are notified as either: newly acquired, where evidence was available that the infection was acquired within 24 months prior to diagnosis; or unspecified, where the infection was acquired more than 24 months prior diagnosis or the period of infection is unspecified. \r\n\r\nDetermination of a case as newly acquired is reliant on public health follow-up and the availability of previous serology test results, with the method and intensity of follow-up varying by jurisdiction and over time. This makes interpretation of incidence using only notification data difficult. For the purposes of this indicator notification rates for both unspecified and newly acquired hepatitis B are presented in the table below and represent prevalence as a surrogate for incidence.\r\n\r\nIt is important to recognise that for hepatitis B infections, notifications to the National Notifiable Disease Surveillance System (NNDSS) represent only a proportion of the total cases and may be influenced by changes to testing patterns.\r\n\r\nFurther information can be found here > http://www9.health.gov.au/cda/source/cda-index.cfm \r\n

This dataset is part of a larger collection

Click to explore relationships graph

Spatial Coverage And Location

text: Australia

Subjects

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Identifiers